According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster ...

On Tuesday, the US Department of Health and Human Services disclosed the end of funding for 22 mRNA vaccine projects — a decision affecting nearly $500 million in federal investments. The announcement ...

In summer 2025, the SARS-CoV-2 JN.1 sublineage became dominant with more resistant variants, such as XFG, LP.8.1, and NB.1.8.1. COVID-19 mRNA boosters were therefore updated for the 2025–2026 season ...

Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Comirnaty (Tozinameran) Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's ...

BANGKOK - An mRNA booster is a follow-up vaccine dose that reminds the immune system what to fight. Think of it like a quick refresher before a big exam.

Simultaneous administration of a COVID-19 mRNA booster shot and the seasonal influenza vaccine slightly increased the risk of systemic reactions during the following week compared with a booster shot ...

A new Centers for Disease Control and Prevention study says booster shots of Pfizer's and Moderna's COVID-19 vaccines proved vital in keeping additional Americans out of the hospital as the omicron ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Effectiveness didn't ...

First and only next-generation protein-based adjuvanted COVID-19 booster approved in Europe Strong immune response against all tested variants of concern Ready to supply for fall-winter COVID-19 ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in ...